Children's susceptibility to chemicals: A review by developmental stage

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 7, Issue 6, 2004, Pages 417-435

  Makri, Anna ^a   Goveia, Michelle ^a   Balbus, John ^a   Parkin, Rebecca ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL CHEMICAL;

CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; DEVELOPMENTAL STAGE; ENVIRONMENTAL EXPOSURE; EXCRETION; FETUS; GASTROINTESTINAL ABSORPTION; GROWTH RATE; GROWTH RETARDATION; HUMAN; INDIVIDUALITY; INFANT; METABOLISM; NEWBORN; PEDIATRICS; PEER REVIEW; REVIEW; RISK ASSESSMENT; SKIN ABSORPTION; TISSUE DISTRIBUTION; TOXICOKINETICS;

ADOLESCENT; AGE FACTORS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; INFANT; INFANT, NEWBORN; RISK ASSESSMENT; XENOBIOTICS;

EID: 8444235339     PISSN: 10937404     EISSN: None     Source Type: Journal    
DOI: 10.1080/10937400490512465     Document Type: Review

References (125)

1. Agency for Toxic Substances and Disease Registry. 2002. Case studies in environmental medicine: pediatric environmental health. ATSDR-HE-CS-2002-0002. Available online at http://www.atsdr.cdc.gov/HEC/CSEM/pediatric/
2. Agunod, M., Yamaguchi, N., Lopez, R., Luhby, A. L., Glass, G. B. 1969. Correlative study of hydrochloric acid, pepsin, and intrinsic factor secretion in newborns and infants. Am. J. Digest. Dis. 14:400-414.
3. Alam, S. N., Roberts, R. J. and Fischer, L. J. 1977. Age-related differences in salicylamide and acetaminophen conjugation in man. J. Pediatr. 90:130-135.
4. American Academy of Pediatrics. 2000. Chemical-biological terrorism and its impact on children: A subject review. Pediatrics 105:662-670.
5. Anderson, H., and Wolff, M. S. 2000. Environmental contaminants in human milk. J. Expos. Anal. Environ. Epidemiol. 10:755-760.
6. Anzenbacher, P., and Anzenbacherova, E. 2001. Cytochromes P450 and metabolism of xenobiotics. CMLS Cell. Molec. Life Sci. 58:737-747.
7. Arana, A., Morton, N. S., and Hansen, T. G. 2001. Treatment with paracetamol in infants. Acta Anaesthesiol. Scand. 45:20-29.
8. Aranda, J. V., Hales, B. F., and Rieder, M. J. 1997. Developmental pharmacology. In Neonatal-perinatal medicine: Diseases of the fetus and infant, eds. A. A. Fanaroff and R. J. Martin, pp.131-156. St. Louis, MO: Mosby.
9. Atkinson, H. C., Begg, E. J., and Darlow, B. A. 1988. Drugs in human milk. Clinical pharmacokinetic considerations. Clin. Pharmacokinet. 14:217-240.
10. Bates, M. D., and Balistreri, W. F. 2004. Development and function of the liver and biliary system. In Nelson textbook of pediatrics, eds. R. E. Behrman, R. M. Kliegman, and H. M. Jenson, pp.1304-1308. Philadelphia: W. B. Saunders.
11. Bearer, C. F. 1997. Occupational and environmental risks to the fetus In Neonatal-perinatal medicine: Diseases of the fetus and infant, eds. A. A. Fanaroff and R. J. Martin, pp.188-202. St. Louis, MO: Mosby.
12. Berlin, C. M. 1992. The excretion of drugs and chemicals in human milk In Pediatric pharmacology: Therapeutic principles in practice, eds. S. J. Yaffe and V. J. Aranda, pp.205-211. Philadelphia: W. B. Saunders.
13. Bernardo, L. M. 2001. Pediatric implications in bioterrorism part I: Physiologic and psychosocial differences. Int. J. Trauma Nurs. 7:14-16.
14. Besunder, J. B., Reed, M. D., and Blumer, J. L. 1988. Principles of drug biodisposition in the neonate: A critical evaluation of the pharmacokinetic- pharmacodynamic interface (Part I). Clin. Pharmacokinet. 14:189-216.
15. Blumer, J. L., and Reed, M. D. 1992. Principles of neonatal pharmacology. In Pediatric pharmacology: Therapeutic principles in practice, eds. S. J. Yaffe and J. V. Aranda, pp.164-177. Philadelphia: W. B. Saunders.
16. Burri, P. H. 1997. Postnatal development and growth. In The lung: Scientific foundations, eds. R. G. Crystal and J. B. West, pp.1013-1026. Philadelphia: Lippincott-Raven.
17. Byer, A. J., Traylor, T. R., and Semmer, J. R. 1982. Acetaminophen overdose in the third trimester of pregnancy. J. Am. Med. Assoc. 247:3114-3115.
18. Calabrese, E. J. 1986a. Gastrointestinal/dermal/pulmonary absorption of xenobiotics: Effect of age. In Age and susceptibility to toxic substances, ed. E. J. Calabrese, pp.5-24. New York: John Wiley & Sons.
19. Calabrese, E. J. 1986b. Hematological factors. In Age and susceptibility to toxic substances, ed. E. J. Calabrese, pp.79-94. New York: John Wiley & Sons.
20. Chuang, E., and Haber, B. A. 1998. Bile secretion and its control in the mature and immature organism. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.1457-1471. Philadelphia: W. B. Saunders.
21. Cieslak, T. J., and Henretig, F. M. 2003. Bioterrorism. Pediatr. Ann. 32:154-165.
22. Clewell, R. A., and Cearhart, J. M. 2002. Pharmacokinetics of toxic chemicals in breast milk: Use of PBPK models to predict infant exposure. Environ. Health Perspect. 110:A333-A337.
23. Cohen Hubal, E. A., Sheldon, L. S., Burke, J. M., McCurdy, T. R., Berry, M. R., Rigas, M. L., Zartarian, V. G., and Freeman, N. C. G. 2000. Children's exposure assessment: A review of factors influencing children's exposure, and the data available to characterize and assess that exposure. Environ. Health Perspect. 108:475-486.
24. Daee, A., Robinson, P., Lawson, M., Turpin, J. A., Gregory, B., and Tobias, J. D. 2002. Psychologic and physiologic effects of dieting in adolescents. South. Med. J. 95:1032-1041.
25. de Wildt, S. N., Kearns, G. L., Leeder, J. S., and van den Anker, J. N. 1999. Cytochrome P450 3A: Ontogeny and drug disposition. Clin. Pharmacokinet. 37:485-505.
26. Dietert, R. R., Etzel, R. A., Chen, D., Halonen, M., Holladay, S. D., Jarabek, A. M., Landreth, K., Peden, D. B., Pinkerton, K., Smialowicz, R. J., and Zoetis, T. 2000. Workshop to identify critical windows of exposure for children's health: Immune and respiratory systems work group summary. Environ. Health Perspect. 108(suppl.):483-490.
27. Faustman, E. M., Silbernagel, S. M., Fenske, R. A., Burbacher, T. M., and Ponce, R. A. 2000. Mechanisms underlying children's susceptibility to environmental toxicants. Environ. Health Perspect. 108(suppl.):13-21.
28. Fraser, F. C. 1992. Teratology. In Pediatric pharmacology: Therapeutic principles in practice, eds. S. J. Yaffe and J. V. Aranda, pp.107-110. Philadelphia: W. B. Saunders.
29. Gerde, P., and Scott, B. R. 2001. A model for absorption of low-volatile toxicants by the airway mucosa. Inhal. Toxicol. 13:903-929.
30. Ghadially, R., and Shear, N. H. 1992. Topical therapy and percutaneous absorption. In Pediatric pharmacology: Therapeutic principles in practice, eds. S. J. Yaffe and J. V. Aranda, pp.72-77. Philadelphia: W. B. Saunders.
31. Gitterman, B. A., and Bearer, C. F. 2001. A developmental approach to pediatric environmental health. Pediatr. Clin. North Am. 48:1071-1083.
32. Goveia, M., Makri, A., and Balbus, J. 2003. Pediatric susceptibility to chemicals. Report to the U.S. Environmental Protection Agency, Office of Water. Washington, DC: George Washington University.
33. Gow, P. J., Ghabrial, H., Smallwood, R. A., Morgan, D. J., and Ching, M. S. 2001. Neonatal hepatic drug elimination. Pharmacol. Toxicol. 88:3-15.
34. Gram, T. E. 1997. Drug absorption and distribution. In Modern pharmacology with clinical applications, eds. C. R. Craig and R. E. Stitzel, pp.13-24. Boston: Little, Brown.
35. Grand, R. J., Watkins J. B., and Torti, F. M. 1976. Development of the human gastrointestinal tract: A review. Gastroenterology 70:790-810.
36. Gregus, Z., and Klaassen, C. D. 1998. Hepatic disposition of xenobiotics during prenatal and early postnatal development. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.1472-1493. Philadelphia: W. B. Saunders.
37. Griffith, G. H., Owen, G. M., Campbell, H., and Shields, R. 1968. Gastric emptying in health and in gastroduodenal disease. Gastroenterology 54:1-7.
38. Culson, B. L., Jameson, C. W., Mahaffey, K. R., Mizon, K. J., Patison, N., Law, A. J., Korsch, M. J., and Salter, M. A. 1998. Relationships of lead in breast milk to lead in blood, urine, and diet of the infant and mother. Environ. Health Perspect. 106:667-674.
39. Guo, Y. L., Lambert, G. H., and Hsu, C. C. 1995. Growth abnormalities in the population exposed in utero and early postnatally to polychlorinated biphenyls and dibenzofurans. Environ. Health Perspect. 103(suppl.):117-122.
40. Gupta, M., and Brans, Y. W. 1978. Gastric retention in neonates. Pediatrics 62:26-29.
41. Gurunathan, S., Robson, M., Freeman, N., Buckley, B., Roy, A., Meyer, R., Bukowski, J., and Lioy, P. J. 1998. Accumulation of chlorpyrifos on residential surfaces and toys accessible to children. Environ. Health Perspect. 106:9-16.
42. Hakkola, J., Pelkonen, O., Pasanen, M., and Raunio, H. 1998. Xenobiotic-metabolizing cytochrome P450 enzymes in the human fetoplacental unit: Role in intrauterine toxicity. Crit. Rev. Toxicol. 28:35-72.
43. Hall, B. 1975. Changing composition of human milk and early development of an appetite control. Lancet 1:779-781.
44. Hattis, D., Ginsberg, G., Sonawane, B., Smolenski, S., Russ, A., Kozlak, M., and Goble, R. 2003. Differences in pharmacokinetics between children and adults-II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Risk Anal. 23:117-142.
45. Heimann, G. 1980. Enteral absorption and bioavailability in children in relation to age. Eur. J. Clin. Pharmacol. 18:43-50.
46. Hein, K. 1992. Drug therapeutics in the adolescent. In Pediatric pharmacology: Therapeutic principles in practice, eds. S. J. Yaffe and J. V. Aranda, pp.220-233. Philadelphia: W. B. Saunders.
47. Heubi, J. E., Balistreri, W. F., and Suchy, F. J. 1982. Bile salt metabolism in the first year of life J. Lab. Clin. Med. 100:127-136.
48. Heyman, S. 1998. Gastric emptying in children. J. Nucl. Med. 39:865-869.
49. Hill, M. D., and Abramson, F. P. 1988. The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state. Clin. Pharmacokinet. 14:156-170.
50. Hudson, A. W. 1998. Normal and abnormal structural development of the lung. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.1033-1046. Philadelphia: W. B. Saunders.
51. Hogue, S. L., and Phelps, S. J. 1992. Pharmacokinetically based drug interactions in the pediatric patient. In Pediatric pharmacology: Therapeutic principles in practice, eds. S. J. Yaffe and J. V. Aranda, pp.566-582. W. B. Saunders.
52. Holbrook, K. A. 1998. Structural and biochemical organogenesis of skin and cutaneous appendages in the fetus and newborn. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.729-752. Philadelphia: W. B. Saunders.
53. Hoover, S. M. 1990. Exposure to persistent organochlorines in Canadian breast milk: A probabilistic assessment. Risk Anal. 19: 527-545.
54. Hsu, S. T, Ma, C. I., Hsu, S. K., Wu, S. S., Hsu, N. H., Yeh, C. C., and Wu, S. B. 1985. Discovery and epidemiology of PCB poisoning in Taiwan: a four-year followup. Environ. Health Perspect. 59:5-10.
55. ILSI. 2002. Draft report-Workshop to Develop a Framework for Assessing Risks to Children from Exposures to Environmental Agents. Washington, DC: ILSI Risk Science Institute.
56. Irwin, C. E., Jr., Burg, S. J., and Uhler, C. C. 2002. America's adolescents: Where have we been, where are we going? J. Adolesc. Health 31:91-121.
57. James, D. S., Lambert, W. E., Mermier, C. M., Stidley, C. A., Chick, T. W., and Samet, J. M. Oronasal distribution of ventilation at different ages. Arch. Environ. Health 52:118-123.
58. John, E. G., and Guignard, J. P. 1998. Development of renal excretion of drugs during ontogeny. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.188-193. Philadelphia: W. B. Saunders.
59. Juchau, M. R. 1972. Mechanisms of drug biotransformation reactions in the placenta. Fed. Proc. 31:48-51.
60. Juchau, M. R., Chao, S. T., and Omiecinski, C. J. 1983. Drug metabolism by the human fetus. In Handbook of clinical pharmacokinetics, eds. M. Gibaldi and L. Prescott, pp.58-78. New York: ADIS Health Science.
61. Kacew, S. 1997. General principles in pediatric pharmacology and toxicology. In Environmental toxicology and pharmacology of human development, eds. S. Kacew and G. H. Lambert, pp.1-14. Washington, DC: Taylor & Francis.
62. Kapitulnik,. J., Horner-Mibashan, R., Blondheim, S. H., Kaufmann, N. A., and Russell, A. 1975. Increase in bilirubin-binding affinity of serum with age of infant. J. Pediatr. 86:442-445.
63. Kauffman, R. E. 1992. Drug therapeutics in the infant and child. In Pediatric pharmacology: Therapeutic principles in practice, eds. S. J. Yaffe and J. V. Aranda, pp.212-21 9. Philadelphia: W. B. Saunders.
64. Knobeloch, L., Salna, B., Hogan, A., Postle, J., and Anderson, H. 2000. Blue babies and nitrate-contaminated well water. Environ. Health Perspect. 108:675-678.
65. Koren, G. 1990. Changes in drug disposition in pregnancy and their clinical implications. In Maternal-fetal toxicology: A clinicians' guide, ed G. Koren, pp.3-13. New York: Marcel Dekker.
66. Kurzel, R. B. 1990. Can acetaminophen excess result in maternal and fetal toxicity? South. Med. J. 83:953-955.
67. Laine-Alava, M. T., and Minkkinen, U. K. 1997. Variation of nasal respiratory pattern with age during growth and development. Laryngoscope 107:386-390.
68. Landrigan, P. J., Sonawane, B., Mattison, D., McCally, M., and Garg, A. 2002. Chemical contaminants in breast milk and their impacts on children's health: An overview. Environ. Health Perspect. 110:A313-A315.
69. Lanphear, B. P. and Roghmann, K. J. 1997. Pathways of lead exposure in urban children. Environ. Res. 74:67-73.
70. Lanphear, B. P., Matte, T. D., Rogers, J., Clickner, R. P., Dietz, B., Bornschein, R. L., Succop, P., Mahaffey, K. R., Dixon, S., Galke, W., Rabinowitz, M., Farfel, M., Rohde, C, Schwartz, J., Ashley, P., and Jacobs, D. E. 1998. The contribution of lead-contaminated house dust and residential soil to children's blood lead levels: a pooled analysis of 12 epidemiologic studies. Environ. Res. 79:51-68.
71. Lawrence, R. A., and Lawrence, R. M. 1949. Breastfeeding: A guide for the medical profession. St. Louis, MO: Mosby.
72. Leake, R. D., and Trygstad, C. W. 1977. Glomerular filtration rate during the period of adaptation to extrauterine life. Pediatr. Res. 11: 959-962.
73. Lebenthal, E., Lee, P. C., and Heitlinger, L. A. 1983. Impact of development of the gastrointestinal tract on infant feeding. J. Pediatr. 102:1-9.
74. Long, S. S., and Swenson, R. M. 1977. Development of anaerobic fecal flora in healthy newborn infants. J. Pediatr. 91:298-301.
75. Lonnerdal, B., Forsum, E., and Hambraeus, L. 1976. A longitudinal study of the protein, nitrogen, and lactose contents of human milk from Swedish well-nourished mothers. Am. J. Clin. Nutr. 29:1127-1133.
76. Lukens, J. N. 1987. Landmark perspective: The legacy of well-water methemoglobinemia. J. Am. Med. Assoc. 257:2793-2795.
77. Mathieu-Nolf, M. 2002. Poisons in the air: a cause of chronic disease in children. J. Toxicol. Clin. Toxicol. 40:483-491.
78. McCarthy, J., and Gram, T. E. 1997. Drug metabolism and disposition in pediatric and gerontological stages of life. In Modern pharmacology with clinical applications, eds. C. R. Craig and R. E. Stitzel, pp.43-48. Boston: Little, Brown.
79. Mennella, J. A., and Beauchamp, G. K. 1992. Developmental changes in nasal airflow patterns. Acta Otolaryngol. 112:1025-1031.
80. Miller, R. P., Roberts, R. J., and Fischer, L. J. 1976. Acetaminophen elimination kinetics in neonates, children, and adults. Clin. Pharmacol. Ther. 19:284-294.
81. Moon, K., and Hillemeier, A. C. 1998. Fetal and neonatal intestinal motility. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.1383-1386. Philadelphia: W. B. Saunders.
82. Morris, J. B. 2001. Overview of upper respiratory tract vapor uptake studies. Inhal. Toxicol. 13:335-345.
83. Morselli, P. L. 1977. Drug absorption. In Drug disposition during development, ed. P. L. Morselli, pp.51-60. New York: Spectrum.
84. Morselli, P. L., Franco-Morselli, R., and Bossi, L. 1980. Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin. Pharmacokinet. 5:485-527.
85. Nagourney, B. A., and Aranda, J. V. 1998. Physiologic differences of clinical significance. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.239-249. Philadelphia: W. B. Saunders.
86. Nau, H., and Plonait, S. L. 1998. Physicochemical and structural properties regulating placental drug transfer. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.146-160. Philadelphia: W. B. Saunders.
87. Needham, L. L., and Wang, R. Y. 2002. Analytic considerations for measuring environmental chemicals in breast milk. Environ. Health Perspect. 110:A317-A324.
88. Needleman, H. L., Rabinowitz, M., Leviton, A., Linn, S., and Schoenbaum, S. 1984. The relationship between prenatal exposure to lead and congenital anomalies. J. Am. Med. Assoc. 251:2956-2959.
89. Notarianni, L. J., Belk, D., Aird, S. A., and Bennett, P. N. 1995. An in vitro technique for the rapid determination of drug entry into breast milk. Br. J. Clin. Pharmacol. 40:333-337.
90. O'Halloran, K., and Spickett, J. T. 1992. The interaction of lead exposure and pregnancy. Asia Pacific J. Public Health 6:35-39.
91. Olin, S. S. 1998. Research needs: recommendations of an ILSI working group on age-related differences in susceptibility. Food Addit. Contam.15(suppl.):53-54.
92. Pineiro-Carrero, V. M., Andres, J. M., Davis, R., H., and Mathias, J. R. 1988. Abnormal gastroduodenal motility in children and adolescents with recurrent functional abdominal pain. J. Pediatr. 113:820-825.
93. Pinkerton, K. E., and Joad, J. P. 2000. The mammalian respiratory system and critical windows of exposure for children's health. Environ. Health Perspect. 108:457-462.
94. Plunkett, L. M., Turnbull, D., and Rodricks, J. V. 1992. Differences between adults and children affecting exposure assessment. In Similarities and differences between children and adults: Implications for risk assessment, eds. P. S. Guzelian, C. J. Henry, and S. S. Olin, pp.79-94. Washington, DC: ILSI Press.
95. Poissonnet, C. M., LaVelle, M., and Burdi, A. R, 1988. Growth and development of adipose tissue. J. Pediatr. 113:1-9.
96. Reed, M. D., and Gal, P. 2004. Principles of drug therapy. In Nelson textbook of pediatrics, eds. R. E. Behrman, R. M. Kliegman, and H. M. Jenson, pp.2427-2432. Philadelphia: W. B. Saunders.
97. Reed, M. D., and Blumer, J. L. 1997. Pharmacologic treatment of the fetus. In Neonatal-perinatal medicine: Diseases of the fetus and infant, eds. A. A. Fanaroff and R. J. Martin, pp.157-187. St. Louis, MO: Mosby.
98. Reiquam, C, Allen, R., and Akers, D. 1965. Normal and abnormal small bowel lengths. Am. J. Dis. Child. 109:447-451.
99. Rieder, M. J. 1990. Drugs and breastfeeding. In Maternal-fetal toxicology: A clinicians' guide, ed. G. Koren, pp.63-85. New York: Marcel Dekker.
100. Rieder, M. J. 1998. Drug excretion during lactation. In Fetal and neonatal physiology, eds. R. A. Polin and W. W. Fox, pp.256-265. Philadelphia: W. B. Saunders.
101. Ring, J. A., Ghabrial, H., Ching, M. S., Smallwood, R. A., and Morgan, D. J. 1999. Fetal hepatic drug elimination. Pharmacol. Ther. 84:429-445.
102. Rivera-Calimlim, L. 1987. The significance of drugs in breast milk: pharmacokinetic considerations. Clin. Perinatol. 14:51-70.
103. Roberts, R. J. 1992. Overview of similarities and differences between children and adults: Implications for risk assessments. In Similarities and differences between children and adults: Implications for risk assessment, eds. P. S. Guzelian, C. J. Henry, and S. S. Olin, pp.11-15. Washington, DC: ILSI Press.
104. Rogan, W. J., Gladen, B. C., Hung, K. L., Koong, S. L., Shih, L. Y., Taylor, J. S., Wu, Y. C., Yang, D., Ragan, N. B., and Hsu, C. C. 1988. Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 241:334-336.
105. Rosevear, S. K., and Hope, P. L. 1989. Favourable neonatal outcome following maternal paracetamol overdose and severe fetal distress. Case report. Br. J. Obstet. Gynaecol. 96:491-493.
106. Roux, J. F., and Romney, S. L. 1967. Plasma free fatty acids and glucose concentrations in the human fetus and newborn exposed to various environmental conditions. Am. J. Obstet. Gynecol. 97:268-276.
107. Rozman, K. K., and Klaassen, C. D. 1976. Absorption, distribution, and excretion of toxicants. In Casarett & Doull's toxicology: The basic science of poisons, eds. C. D. Klaassen, pp.91-112. New York: McCraw-Hill.
108. Schreiber, J. S. 2001. Parents worried about breast milk contamination. What is best for baby? Pediatr. Clin. North Am. 48:1113-1127.
109. Siebert, J. R. 1 980. Small-intestine length in infants and children. Am. J. Dis. Child. 134:593-595.
110. Snodgrass, W. R. 1992. Physiological and biochemical differences between children and adults as determinants of toxic response to environmental pollutants. In Similarities and differences between children and adults: Implications for risk assessment, eds. P. S. Guzelian, C. J. Henry, and S. S. Olin, pp.35-42. Washington, DC: ILSI Press.
111. Sonawane, B. R. 1995. Chemical contaminants in human milk: an overview. Environ. Health Perspect. 103(suppl.):197-205.
112. Stokes, I. M. 1984. Paracetamol overdose in the second trimester of pregnancy. Case report. Br. J. Obstet. Gynaecol. 91:286-288.
113. Stoll, B. J., and Kliegman, R. M. 2004. High-risk pregnancies. In Nelson textbook of pediatrics, eds. R. E. Behrman, R. M. Kliegman, and A. M. Arvin, pp.532-536. Philadelphia: W. B. Saunders.
114. Thompson, G. N., Robertson, E. F., and Fitzgerald, S. 1985. Lead mobilization during pregnancy. Med. J. Aust. 143:131.
115. U.S. Environmental Protection Agency. 1989. Review of the National Ambient Air Quality Standards for lead: Exposure analysis methodology and validation. EPA-450/2-89-011 Washington, DC: U.S. EPA.
116. U.S. Environmental Protection Agency. 1997. Exposure factors handbook volume I: General factors. EPA/600/P-95/002Fa. Washington, DC: U.S. EPA.
117. U.S. Environmental Protection Agency. 2000a. Strategy for research on environmental risks to children. EPA/660/R-00/068. Washington, DC: U.S. EPA.
118. U.S. Environmental Protection Agency. 2000b. Estimated per capita water ingestion in the United States-Based on data collected by the United States Department of Agriculture's 1994-96 Continuing Survey of Food Intakes by Individuals. EPA-822-R-00-008. Washington, DC: U.S. EPA.
119. Vest, M. F. 1965. The development of conjugation mechanisms and drug toxicity in the newborn. Biol. Neonate 8:258-266.
120. Weaver, L. T., Austin, S., and Cole, T. J. 1991. Small intestinal length: a factor essential for gut adaptation. Gut 32:1321-1323.
121. Wershil, B. K. 1992. Gastric function. In Pediatric gastrointestinal disease, vol. 1, eds. W. A. Walker, P. R. Durie, J. R. Hamilton, J. A. Walker-Smith, and J. B. Watkins, pp.71-82. St. Louis, MO: Mosby.
122. West, J. R., Smith, H. W., and Chasis, H. 1948. Glomerular filtration rate, effective renal blood flow, and maximal tubular excretory capacity in infancy. J. Pediatr. 32:10-18.
123. Wolff, M. S. 1993. Lactation. In Occupational and environmental reproductive hazards: A guide for clinicians, ed. M. Paul, pp.60-75. Baltimore, MD: Williams & Wilkins.
124. Zeltner, T. B., Caduff, J. H., Gehr, P., Pfenninger, J., and Burri, P. H. 1987. The postnatal development and growth of the human lung: I. Morphometry. Respir. Physiol. 67:247-267.
125. Ziegler, E. E., Edwards, B. B., Jensen, R. L., Mahaffey, K. R., and Fomon, S. J. 1978. Absorption and retention of lead by infants. Pediatr. Res. 12:29-34.